MICROCHIP TECHNOLOGY INC quarterly report, Q4 FY2003

Business Context and Reporting Period

Company: Microchip Technology Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2003 (Third Quarter of Fiscal Year 2004)
Business Overview: Microchip designs, develops, manufactures, and markets semiconductor products, primarily microcontrollers, memory products, and analog/interface products. The company sells to distributors and original equipment manufacturers (OEMs) across automotive, communications, computing, consumer, and industrial control markets.

Key Financial Metrics

Metric (in thousands) Three Months Ended Dec 31, 2003 Nine Months Ended Dec 31, 2003 Nine Months Ended Dec 31, 2002
Net Sales $177,967 $507,736 $491,796
Gross Profit $97,019 $243,734 $265,561
Gross Margin % 54.5% 48.0% 54.0%
Operating Income $53,852 $111,958 $81,043
Net Income $40,843 $90,417 $55,194
Diluted EPS $0.19 $0.43 $0.26
Cash from Operations (9mo) $247,964
Cash & Short-term Investments $450,440 (as of Dec 31, 2003)
Debt No borrowings under $15M line of credit

Material Changes vs. Prior Period

  • Revenue Growth: Net sales increased 6.3% year-over-year for the quarter and 3.2% for the nine-month period, driven by a 19% increase in unit volume despite an 11% decline in average selling prices.
  • Profitability: Operating income for the nine months ended Dec 31, 2003, rose significantly to $111.9 million from $81.0 million in the prior year. This improvement occurred despite a $31.8 million charge related to the closure of Fab 1 (Chandler, AZ) and expenses for non-operational Fab 3 and Fab 4.
  • Margin Compression: Gross margin for the nine-month period dropped to 48.0% from 54.0% in the prior year, primarily due to the Fab 1 closure charges and lower capacity utilization at new facilities.
  • Accounting Change: The company changed its revenue recognition policy for Asian distributors from Point of Purchase (POP) to Point of Sale (POS). This resulted in a cumulative effect charge of $11.4 million (net of tax) recorded in the prior fiscal year, which impacted comparative figures.
  • Special Charges: The nine-month period included $32.6 million in special charges, primarily related to Fab 1 closure (accelerated depreciation and severance). In the prior year's nine-month period, special charges were $50.8 million, including a $41.5 million impairment charge for Fab 3.

Guidance, Outlook, and Risks

  • Market Conditions: Lead times for semiconductor products are lengthening, and the company ended the quarter with its highest backlog since December 2000. Management expects capacity utilization at Fab 2 to remain at approximately 92% in the fourth quarter.
  • Capital Expenditures: The company intends to spend approximately $60 million over the next 12 months on equipment and facilities. Fab 4 (Gresham, OR) began production in October 2003, though utilization is expected to be low initially.
  • Dividends: A quarterly dividend of $0.035 per share was declared on January 22, 2004, payable March 5, 2004.
  • Risks and Contingencies:
    • Legal Proceedings: Ongoing patent infringement litigation with U.S. Philips Corporation regarding U.S. Patent Nos. 4,689,740 and 5,559,502. The company believes the outcome will not have a material adverse effect but notes inherent uncertainty.
    • Asset Disposal: Fab 3 is classified as "held-for-sale" with a carrying value of $60.2 million. Future market conditions could result in additional impairment charges.
    • Supply Chain: The company relies on third-party contractors for assembly and testing, primarily in Thailand. Disruptions in these operations could impact results.
    • Turns Orders: Revenue visibility is limited due to a high percentage of "turns orders" (orders received and shipped in the same quarter), making forecasting difficult.

Investor Verification Checklist

  • Fab 4 Ramp-Up: Verify the timeline and cost efficiency of bringing the new Fab 4 facility to volume production, as delays could impact margins.
  • Fab 3 Sale: Monitor the status of the Fab 3 sale and potential for additional impairment charges if market conditions deteriorate.
  • Backlog Conversion: Assess the ability to convert the record backlog into actual revenue, given the reliance on "turns orders" and potential supply chain constraints.
  • Legal Exposure: Track developments in the Philips patent litigation for potential injunctions or damages.
  • Inventory Levels: Review distributor inventory levels (currently ~2.2 months) and the company's own inventory days (108 days) to gauge demand sustainability.